SCHEMBL7965142

SCHEMBL7965142

CC(C)(C)c1cc(C=C(C#N)S(=O)(=O)c2ccc(F)cc2F)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
PKM P14618 4/20 0.46
ALDH1A1 P00352 4/20 0.46
POLB P06746 3/20 0.46
HPGD P15428 3/20 0.46
MEN1 O00255 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HSD17B10 Q99714 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
GAA P10253 2/20 0.46
ALOX15 P16050 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALPG P10696 1/20 0.46
ALOX12 P18054 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
EGFR P00533 5/20 0.45
LMNA P02545 3/20 0.43
MAPK1 P28482 2/20 0.41
PPME1 Q9Y570 1/20 0.41
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965139 1.00 KMT2A (0.46) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7965134 1.00 KMT2A (0.46) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7966709 0.89 KMT2A (0.49) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7966712 0.89 KMT2A (0.49) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7966706 0.89 KMT2A (0.49) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7964783 0.86 PKM (0.58) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7964790 0.86 PKM (0.58) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7964786 0.86 PKM (0.58) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7951867 0.84 IGF1R (0.54) KMT2APKMALDH1A1POLBHPGD
SCHEMBL7951862 0.84 IGF1R (0.54) KMT2APKMALDH1A1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 US disclosed